Guangzhou Genedenovo Biotechnology Co., Ltd.
PrivateLast Round
Series A
Aug 1, 2016
Est. Valuation
$22.59M
Company Overview
Guangzhou Genedenovo Biotechnology Co., Ltd. is a biotechnology company that provides high-throughput sequencing and bioinformatics analysis services for academic and clinical research.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Guangzhou Genedenovo Biotechnology Co., Ltd. Comparables
Compare Guangzhou Genedenovo Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.
No public comparables are available for Guangzhou Genedenovo Biotechnology Co., Ltd.. Request access to learn about comparables coverage.
Request accessGuangzhou Genedenovo Biotechnology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 1, 2016 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 7, 2026
Monthly visitors grew 196% MoM, reaching 11.9K.
- Nov 8, 2025
Monthly visitors increased 77% MoM, reaching 4K.
Guangzhou Genedenovo Biotechnology Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Guangzhou Genedenovo Biotechnology Co., Ltd.'s valuation, stock price, and market status.
Is Guangzhou Genedenovo Biotechnology Co., Ltd. a public or private company?
Guangzhou Genedenovo Biotechnology Co., Ltd. is a private company.
What is the current stock price of Guangzhou Genedenovo Biotechnology Co., Ltd.?
Guangzhou Genedenovo Biotechnology Co., Ltd. is a private company with no public stock price. Caplight tracks Guangzhou Genedenovo Biotechnology Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Guangzhou Genedenovo Biotechnology Co., Ltd. worth (valuation)?
Guangzhou Genedenovo Biotechnology Co., Ltd.'s valuation is estimated at $22.6M based on funding round data.
Can I buy Guangzhou Genedenovo Biotechnology Co., Ltd. stock?
Guangzhou Genedenovo Biotechnology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Guangzhou Genedenovo Biotechnology Co., Ltd.'s last funding round?
Guangzhou Genedenovo Biotechnology Co., Ltd.'s most recent funding round was Series A on August 1, 2016.
Who are the main investors in Guangzhou Genedenovo Biotechnology Co., Ltd.?
Investor information for Guangzhou Genedenovo Biotechnology Co., Ltd. is not publicly disclosed.
Will Guangzhou Genedenovo Biotechnology Co., Ltd. IPO soon?
No public IPO plans have been announced for Guangzhou Genedenovo Biotechnology Co., Ltd..
How can I track Guangzhou Genedenovo Biotechnology Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Guangzhou Genedenovo Biotechnology Co., Ltd.'s secondary market activity and sign up for updates.